product

Description

High Flow Nasal Cannula (HFNC), isn’t just a standard nasal cannula cranked up to very high flow rates. It actually takes gas and can heat it to 37℃ with a 100% relative humidity and can deliver 0.21~1.00% fio2 at flow rates of up to 70 liters/min. The flow rate and fio2 can be independently titrated based on your patient’s flow and fi02 requirements.

Humidified high flow nasal cannula therapy is a form of non-invasive respiratory support which has been compared to continuous positive airway pressure (CPAP).

Application

When HFNC is used to deliver oxygen, the flow rates are much higher than can be achieved with traditional nasal cannula. This results in a greater delivery of prescribed oxygen into the lungs, and less entrainment of room air. The oxygen you want to deliver to your patients is not prone to the same effect of dilution!

The main physiological effects of HFNC are maintenance of a known stable alveolar FiO2, optimal humidification of the airway mucosa, reduction of the dead space, generation of a positive end-expiratory pressure (PEEP), ultimately yielding a reduction in the respiratory drive and in the work of breathing.

Advantage

During the pandemic, micomme provided over 7000 units of devices globally.

At present, micomme occupies over 50% market share in high flow filed in China.

Unique one-way airway design, no need for disinfection, reducing equipment turnover time and the workload of medical staff.

Intelligent temperature and humidity control system.

Effectively reduce the dead space with 70L/min high flow.

Specification